BioNTech Innovative Manufacturing Services (IMFS) is a subsidary of BioNTech SE. We are specialized in the development and production of innovative products (viral vectors, cells and ivt mRNA).
Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facilities. We offer contract services for retroviral vector manufacturing for clinical supply. 
The company has more than 500 experienced and highly skilled employees and is always looking for motivated people!

See also www.biontech-imfs.de


Biotechnology

Manufacturing

BioNTech IMFS

Klaus Kuhlcke

Marcel Gandej

Julian Kirch

Andreas Sommer

Erik van Leeuwen

The Quality Control and Assurance team at BioNTech IMFS is responsible for ensuring the highest standards of product quality and compliance throughout the manufacturing process. This team conducts rigorous testing and validation of viral vectors, cells, and mRNA products, adhering to Good Manufacturing Practices (GMP) to guarantee safety and efficacy. They collaborate closely with research and production teams to implement quality management systems and ensure adherence to regulatory requirements, thereby supporting the successful delivery of innovative therapies to clinical supply.

Quality Control and Assurance

About

Team members